Systematic review: The financial burden of surgical complications in patients with ulcerative colitis

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 11, 2015, Pages 1066-1078

  Lindsay, J O ^a   Bergman, A ^b   Patel, A S ^c   Alesso, S M ^c   Peyrin Biroulet, L ^d  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b Takeda Pharmaceuticals International GmbH   (Switzerland)

^c Decision Resources Group   (United Kingdom)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; DRUG THERAPY; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH STATUS; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; ILEITIS; INFERTILITY; INTUBATION; MEDICAL FEE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REOPERATION; SMALL INTESTINE OBSTRUCTION; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; ADULT; COLITIS, ULCERATIVE; COLON RESECTION; COST BENEFIT ANALYSIS; COST OF ILLNESS; ECONOMICS; LENGTH OF STAY; POSTOPERATIVE COMPLICATIONS; POUCHITIS; PROCEDURES;

ADULT; COLECTOMY; COLITIS, ULCERATIVE; COST OF ILLNESS; COST-BENEFIT ANALYSIS; HUMANS; LENGTH OF STAY; POSTOPERATIVE COMPLICATIONS; POUCHITIS; QUALITY OF LIFE;

EID: 84929131381     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13197     Document Type: Article

References (54)

1. Ford AC, Moayyedi P, Hanauer SB,. Ulcerative colitis. BMJ 2013; 346: f432.
2. Bernklev T, Jahnsen J, Lygren I, Henriksen M, Vatn M, Moum B,. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis 2005; 11: 909-18.
3. Janke KH, Raible A, Bauer M, et al,. Questions on life satisfaction (FLZM) in inflammatory bowel disease. Int J Colorectal Dis 2004; 19: 343-53.
4. Cohen RD, Yu AP, Wu EQ, Xie J, Mulani PM, Chao J,. Systematic review: the costs of ulcerative colitis in Western countries. Aliment Pharmacol Ther 2010; 31: 693-707.
5. Gibson PR, Vaizey C, Black CM, et al,. Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study. J Crohns Colitis 2014; 8: 598-606.
6. Dignass A, Lindsay JO, Sturm A, et al,. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: current management. J Crohns Colitis 2012; 6: 991-1030.
7. NICE. Ulcerative colitis. Management in adults, children and young people. NICE clinical guideline 166. Available at: http://www.nice.org.uk/nicemedia/live/14189/64216/64216.pdf (accessed 8 April 2014).
8. Van Assche G, Dignass A, Bokemeyer B, et al,. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013; 7: 1-33.
9. Magro F, Rodrigues A, Vieira AI, et al,. Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts. Inflamm Bowel Dis 2012; 18: 573-83.
10. Williet N, Pillot C, Oussalah A, et al,. Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics. Inflamm Bowel Dis 2012; 18: 1641-6.
11. Rutgeerts P, Sandborn WJ, Feagan BG, et al,. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353: 2462-76.
12. National Institute for Health and Care Excellence. Infliximab for subacute manifestations of ulcerative colitis. Available at: http://www.nice.org.uk/guidance/ta140/resources/guidance-infliximab-for-subacute-manifestations-of-ulcerativecolitis-pdf (accessed 28 July 2014), April 2008.
13. McLaughlin SD, Clark SK, Tekkis PP, Ciclitira PJ, Nicholls RJ,. Review article: restorative proctocolectomy, indications, management of complications and follow-up-a guide for gastroenterologists. Aliment Pharmacol Ther 2008; 27: 895-909.
14. Cooke DM,. Inflammatory bowel disease: primary health care management of ulcerative colitis and Crohn's disease. Nurse Pract 1991; 16: 27-30, 35>-6, 38-9.
15. Fiocchi C,. Towards a 'cure' for IBD. Dig Dis 2012; 30: 428-33.
16. Macdermott RP, Green JA,. Refractory ulcerative colitis treatment. Gastroenterol Hepatol 2007; 3: 64-9.
17. Sica GS, Biancone L,. Surgery for inflammatory bowel disease in the era of laparoscopy. World J Gastroenterol 2013; 19: 2445-8.
18. Smith LE,. A review of twenty-one rectal mucosectomy and ileal pouch pull through procedures. Am Surg 1986; 52: 182-7.
19. Cohen RD, Brodsky AL, Hanauer SB,. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm Bowel Dis 1999; 5: 1-10.
20. D'Haens G,. Infliximab for ulcerative colitis: finally some answers. Gastroenterology 2005; 128: 2161-4.
21. Ara R, Wailoo A,. Using health state utility values in models exploring the cost-effectiveness of health technologies. Value Health 2012; 15: 971-4.
22. ®). SMC No. (721/11). August 2011.
23. Lloyd A, Wild D, Gallop K, Cowell W,. Reimbursement agency requirements for health related quality-of-life data: a case study. Expert Rev Pharmacoecon Outcomes Res 2009; 9: 527-37.
24. Higgins JPT, Green S, (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
25. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
26. Molinier L, Bauvin E, Combescure C, et al,. Methodological considerations in cost of prostate cancer studies: a systematic review. Value Health 2008; 11: 878-85.
27. Nguyen GC, Frick KD, Dassopoulos T,. Medical decision analysis for the management of unifocal, flat, low-grade dysplasia in ulcerative colitis. Gastrointest Endosc 2009; 69: 1299-310.
28. Park KT, Tsai R, Perez F, Cipriano LE, Bass D, Garber AM,. Cost-effectiveness of early colectomy with ileal pouch-anal anastamosis versus standard medical therapy in severe ulcerative colitis. Ann Surg 2012; 256: 117-24.
29. Arseneau KO, Sultan S, Provenzale DT, et al,. Do patient preferences influence decisions on treatment for patients with steroid-refractory ulcerative colitis? Clin Gastroenterol Hepatol 2006; 4: 1135-42.
30. Coakley BA, Divino CM,. Identifying factors predictive of surgical-site infections after colectomy for fulminant ulcerative colitis. Am Surg 2012; 78: 481-4.
31. Coakley BA, Telem D, Nguyen S, Dallas K, Divino CM,. Prolonged preoperative hospitalization correlates with worse outcomes after colectomy for acute fulminant ulcerative colitis. Surgery 2013; 153: 242-8.
32. Kumar N, Kumar A, Thompson CC,. Postoperative bleeding after colon and rectal surgery by preoperative diagnosis: a nationwide analysis. Gastroenterology 2013; 144: S1072.
33. Loftus EV, Leonard P, Yang M, Hayes O, Mulani P, Chao J,. A retrospective study of colectomy complications and their associated costs for patients with ulcerative colitis. Gastroenterology 2012; 142: S198.
34. Swenson BR, Hollenbeak CS, Poritz LS, Koltun WA,. Modified two-stage ileal pouch-anal anastomosis: equivalent outcomes with less resource utilization. Dis Colon Rectum 2005; 48: 256-61.
35. Telem DA, Vine AJ, Swain G, et al,. Laparoscopic subtotal colectomy for medically refractory ulcerative colitis: the time has come. Surg Endosc 2010; 24: 1616-20.
36. Punekar YS, Hawkins N,. Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis. Eur J Health Econ 2010; 11: 67-76.
37. Sileri P, Sthory R, McVeigh E, et al,. Adhesions are common and costly after open pouch surgery. J Gastrointest Surg 2008; 12: 1239-45.
38. Tsai HH, Punekar YS, Morris J, Fortun P,. A model of the long-term cost effectiveness of scheduled maintenance treatment with infliximab for moderate-to-severe ulcerative colitis. Aliment Pharmacol Ther 2008; 28: 1230-9.
39. Mennigen R, Senninger N, Bruewer M, Rijcken E,. Pouch function and quality of life after successful management of pouch-related septic complications in patients with ulcerative colitis. Langenbecks Arch Surg 2012; 397: 37-44.
40. Aberg H, Pahlman L, Karlbom U,. Small-bowel obstruction after restorative proctocolectomy in patients with ulcerative colitis. Int J Colorectal Dis 2007; 22: 637-42.
41. Kachra R, Bandali M, Proulx MC, et al,. Long-term complications responsible for hospital readmission following a colectomy for ulcerative colitis: a population-based analysis. Gastroenterology 2011; 140: S770.
42. ® in the treatment of ulcerative colitis in England and Wales. Manufacturer submission for NICE TA140. Available at: http://www.nice.org.uk/nicemedia/live/11732/37557/37557.pdf (accessed 2 June 2014), 2007.
43. Clavien PA, Barkun J, de Oliveira ML, et al,. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187-96.
44. Waljee A, Waljee J, Morris AM, Higgins PD,. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut 2006; 55: 1575-80.
45. van Tilborg TC, Eijkemans MJ, Laven JS, et al,. The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial. BMC Womens Health 2012; 12: 29.
46. Aarts JW, van Empel IW, Boivin J, Nelen WL, Kremer JA, Verhaak CM,. Relationship between quality of life and distress in infertility: a validation study of the Dutch FertiQoL. Hum Reprod 2011; 26: 1112-8.
47. Chachamovich JR, Chachamovich E, Ezer H, Fleck MP, Knauth D, Passos EP,. Investigating quality of life and health-related quality of life in infertility: a systematic review. J Psychosom Obstet Gynaecol 2010; 31: 101-10.
48. Silvestri MT, Hurst RD, Rubin MA, Michelassi F, Fichera A,. Chronic inflammatory changes in the anal transition zone after stapled ileal pouch-anal anastomosis: is mucosectomy a superior alternative? Surgery 2008; 144: 533-7; discussion 537-9.
49. Fichera A, Silvestri MT, Hurst RD, Rubin MA, Michelassi F,. Laparoscopic restorative proctocolectomy with ileal pouch anal anastomosis: a comparative observational study on long-term functional results. J Gastrointest Surg 2009; 13: 526-32.
50. Hallberg H, Stahlberg D, Akerlund JE,. Ileal pouch-anal anastomosis (IPAA): functional outcome after postoperative pelvic sepsis. A prospective study of 100 patients. Int J Colorectal Dis 2005; 20: 529-33.
51. Fazio VW, Kiran RP, Remzi FH, et al,. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg 2013; 257: 679-85.
52. Mennigen R, Senninger N, Bruwer M, Rijcken E,. Impact of defunctioning loop ileostomy on outcome after restorative proctocolectomy for ulcerative colitis. Int J Colorectal Dis 2011; 26: 627-33.
53. Hicks CW, Hodin RA, Bordeianou L,. Possible overuse of 3-stage procedures for active ulcerative colitis. JAMA Surg 2013; 148: 658-64.
54. Boostrom S, Dozois E, Baek S, et al,. (P150) Long term surgical outcomes following laparoscopic ileal pouch-anal anastomosis in patients with chronic ulcerative colitis: 5 year follow up of a case matched study. American Society of Colon and Rectal Surgeons Annual Scientific Meeting April 27-May 1, 2013, Phoenix, AZ.